In the ninth episode, Nicholas and Lana unpack several longevity launches making waves, and why regulatory clearance, novelty, and clinical data are 3 separate things brands shouldn't blur together.

Why responsible innovation means asking whether yesterday's formulations still reflect today's best science—not just launching the next new ingredient.

TriNutra is presenting new data on its standardized black seed oil ingredient at SupplySide Global, adding to a growing body of research on how gut bacteria and the body's stress response may influence each other.

A randomized crossover trial finds that formulation, not just dose, determines how much of the hops-derived compound xanthohumol actually reaches the bloodstream.

A new 12-week trial adds controlled data to a question that matters for manufacturers positioning creatine beyond sports nutrition: does its muscle-building evidence hold up in adults over 45, including those not following a structured exercise program?

A randomized, crossover trial found that ThymoDream, a standardized black cumin seed oil, raised endogenous melatonin levels and improved several sleep measures over 7 nights, with lower reported daytime sleepiness than synthetic melatonin.

Piping Rock Health Products has launched a 300-mg NMN gummy under its Vitafusion brand, arriving less than a year after the FDA reversed its position on whether the ingredient could legally be sold as a dietary supplement.

The Indian branded-ingredient supplier has closed a growth investment from NDude Labs to expand clinical research and establish a dedicated US commercial operation, reflecting investor interest in ingredient companies that lead with published data.